Screen-detected breast cancers have significantly lower rates of HER2 positivity which may explain the survival advantage in women diagnosed following mammography compared to those diagnosed with symptoms. A study of more than 100,000 cases of invasive breast cancer from the BreastSurgANZ Quality Audit has shown quite different molecular profiles in screen-detected versus other breast cancers. ...
Why are there fewer HER2 positive breast cancers in screen-detected patients?
By Mardi Chapman
1 Aug 2018